Physician profile
Patrick Camara
NPI 1194599514
$401.95
in general payments reported to CMS, 2019-2025
9 companies · $91.40 in 2025
The $91.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $311 · 2025: $91.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $99.14 | 2024 | Breztri, Airsupra |
| Corcept Therapeutics | $92.50 | 2024 | Korlym |
| Abbvie INC. | $49.64 | 2024-2025 | |
| Lundbeck LLC | $45.83 | 2024-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $25.30 | 2024 | M-M-R II, Gardasil 9, Capvaxive |
| Mylan Specialty L.P. | $24.94 | 2024 | Yupelri |
| Edwards Lifesciences Corporation | $23.12 | 2025 | |
| Amgen INC. | $21.22 | 2024 | Evenity |
| Becton, Dickinson and Company | $20.26 | 2025 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Camara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.